We are live on ! Find out more
Saturna Capital

Saturna Capital Portfolio holdings

AUM $8.19B Turnover 10.53%
1-Year Est. Return 42.01%
This Fund
S&P 500
This Quarter Est. Return
+10.3%
1 Year Est. Return
+42.01%
3 Year Est. Return
+117.49%
5 Year Est. Return
+160.24%
10 Year Est. Return
+637.05%
AUM
$3.7B
AUM Growth
+$254M
Cap. Flow
-$65M
Cap. Flow %
-1.76%
Top 10 Hldgs %
30.99%
Holding
194
New
8
Increased
30
Reduced
27
Closed
6
Avg Time Held
3.9 years
Top 10 Avg Time Held
2.9 years
Top 20 Avg Time Held
3.5 years

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$13.2M
2
SONY icon
Sony
SONY
+$1.09M
3
FRO icon
Frontline
FRO
+$741K
4
ORCL icon
Oracle
ORCL
+$550K
5
PHG icon
Philips
PHG
+$435K

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$23.5M
2
CELG
Celgene Corp
CELG
+$20.4M
3
MSFT icon
Microsoft
MSFT
+$14.7M
4
APD icon
Air Products & Chemicals
APD
+$13.5M
5
PH icon
Parker-Hannifin
PH
+$5.19M

Sector Composition

Rank Sector Weight
1 Technology 35.73%
2 Industrials 19.8%
3 Healthcare 19.73%
4 Consumer Staples 12.69%
5 Consumer Discretionary 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
BMY icon
26
Bristol-Myers Squibb
BMY
$122B
$58.4M 1.58%
909,053
+230,789
+34% +$13.2M
2013 Q2
26 quarters
ITW icon
27
Illinois Tool Works
ITW
$77.5B
$56.9M 1.54%
316,631
– –
2013 Q2
26 quarters
INTC icon
28
Intel
INTC
$475B
$56M 1.52%
935,722
– –
2013 Q2
26 quarters
UNP icon
29
Union Pacific
UNP
$172B
$55.2M 1.49%
305,512
– –
2013 Q2
26 quarters
HON icon
30
Honeywell
HON
$67B
$54.3M 1.47%
325,786
+212
+0.1% +$34.7K
2013 Q2
26 quarters
PPG icon
31
PPG Industries
PPG
$23.9B
$54.2M 1.47%
406,213
– –
2013 Q2
26 quarters
MCHP icon
32
Microchip Technology
MCHP
$40.1B
$53.5M 1.45%
1,021,520
-7,000
-0.7% -$338K
2013 Q2
26 quarters
KEYS icon
33
Keysight
KEYS
$56.4B
$51.4M 1.39%
501,179
– –
2014 Q4
20 quarters
LOW icon
34
Lowe's Companies
LOW
$111B
$51.1M 1.38%
426,578
– –
2013 Q2
26 quarters
CSL icon
35
Carlisle Companies
CSL
$13.3B
$50.4M 1.36%
311,200
-20,000
-6% -$3.08M
2013 Q2
26 quarters
PFE icon
36
Pfizer
PFE
$169B
$46.7M 1.26%
1,255,856
+1,117
+0.1% +$39.8K
2013 Q2
26 quarters
PH icon
37
Parker-Hannifin
PH
$121B
$46.2M 1.25%
224,562
-26,800
-11% -$5.19M
2013 Q2
26 quarters
FAST icon
38
Fastenal
FAST
$58.5B
$44.5M 1.2%
2,409,016
– –
2013 Q2
26 quarters
SAP icon
39
SAP
SAP
$259B
$44.3M 1.2%
330,442
– –
2013 Q2
26 quarters
GPC icon
40
Genuine Parts
GPC
$18.5B
$41M 1.11%
386,365
– –
2013 Q2
26 quarters
CLX icon
41
Clorox
CLX
$10.5B
$38.6M 1.04%
251,284
-100
-0% -$14.9K
2013 Q2
26 quarters
ABT icon
42
Abbott
ABT
$181B
$37.3M 1.01%
429,025
– –
2013 Q2
26 quarters
ORCL icon
43
Oracle
ORCL
$389B
$37.2M 1.01%
702,987
+10,000
+1% +$550K
2013 Q2
26 quarters
CL icon
44
Colgate-Palmolive
CL
$75B
$37M 1%
537,666
– –
2013 Q2
26 quarters
CNI icon
45
Canadian National Railway
CNI
$73.6B
$36M 0.97%
398,000
+400
+0.1% +$35.9K
2013 Q2
26 quarters
LECO icon
46
Lincoln Electric
LECO
$14.3B
$34.9M 0.95%
361,200
– –
2013 Q2
26 quarters
LIN icon
47
Linde
LIN
$230B
$34.5M 0.93%
161,871
+200
+0.1% +$40.3K
2018 Q4
4 quarters
APD icon
48
Air Products & Chemicals
APD
$66.7B
$33.4M 0.9%
141,975
-60,000
-30% -$13.5M
2013 Q2
26 quarters
ABBV icon
49
AbbVie
ABBV
$504B
$32.4M 0.88%
366,476
-4,000
-1% -$332K
2013 Q2
26 quarters
KMB icon
50
Kimberly-Clark
KMB
$35.1B
$32.2M 0.87%
234,200
– –
2013 Q2
26 quarters
1
2
3 4 5

Similar funds

Ballentine Partners
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bridges Investment Management
Bridges Investment Management Omaha, Nebraska $8.22B AUM 21.38% 1-Year Est. Return
Welch & Forbes
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
Apollon Wealth Management
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
Soros Fund Management
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
Everett Harris & Co
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
Kingsview Wealth Management
Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return

Saturna Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Saturna Capital held 194 positions worth $3.7B, up 7.4% from $3.44B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Saturna Capital's Q4 2019 filing shows 8 new, 30 increased, 27 reduced and 6 closed positions. Its largest new stake was Sony: 87,500 shares worth $1.19M. The largest sale was Johnson & Johnson, an estimated $23.5M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 34% a quarter earlier, followed by Industrials and Healthcare.

  • Saturna Capital's largest Q4 2019 buy was Sony: 87,500 shares worth $1.19M.
  • Saturna Capital added most to Bristol-Myers Squibb in Q4 2019, an estimated $13.2M increase.
  • Saturna Capital's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $23.5M.
  • Saturna Capital fully exited Celgene Corp in Q4 2019, selling an estimated $20.4M.
  • Saturna Capital's ten largest holdings make up 31% of its $3.7B portfolio in Q4 2019.
  • Saturna Capital opened 8 new positions and closed 6 in Q4 2019.
  • Saturna Capital's portfolio value rose 7.4% quarter-over-quarter to $3.7B.

Based on Saturna Capital's 13F filing for Q4 2019, filed 13 Feb 2020.